Pregnant women admitted to Tampa General Hospital, Tampa, Fla., were cultured for group B streptococci (GBS). Culture swabs were placed into enriched, selective Todd-Hewitt medium and were quantitated for GBS. The broth cultures were tested by slide coagglutination before incubation and after 5 and 20 h of incubation. Group B streptococci (GBS) are among the most frequent causes of neonatal sepsis, meningitis, and respiratory distress. Approximately 1% of the infants colonized with GBS at skin sites (umbilicus, rectum, and throat) develop early-onset sepsis during the first week of life. This disease has a 50% mortality rate, despite antimicrobial therapy (3).
Group B streptococci (GBS) are among the most frequent causes of neonatal sepsis, meningitis, and respiratory distress. Approximately 1% of the infants colonized with GBS at skin sites (umbilicus, rectum, and throat) develop early-onset sepsis during the first week of life. This disease has a 50% mortality rate, despite antimicrobial therapy (3) .
GBS have been shown to colonize the vaginal tracts of 7 to 20% of all pregnant women (5, 9, 10) . Infants usually become infected with GBS during birth. Data from our laboratory indicate that 70o of the neonates delivered by mothers colonized with GBS are colonized by the organism at external skin sites. Our data show further that heavily colonized infants (¢a105 GBS per culture swab at two or more external skin sites) are symptomatic for early-onset sepsis (11). Ancona et al. (1) and Bobitt et al. (6) noted in independent studies that women heavily colonized with GBS delivered infants who were also heavily colonized with the bacteria. If these women at high risk of delivering symptomatic infants could be rapidly and accurately identified in routine prenatal screening, the morbidity and mortality rates of early-onset GBS sepsis would be significantly reduced. We describe in this paper the combined use of an enriched, selective broth medium and slide co-agglutination to screen such maternity patients. One swab from each dual-culture swab set was inoculated into enriched, selective Todd-Hewitt broth containing 1% yeast extract, 10 ,ug of colistin methane sulfonate per ml, and 15 ,ug of nalidixic acid per ml (GIBCO Diagnostics, Madison, Wis.). The broth cultures were tested for GBS by slide coagglutination (Phadebact Streptococcus Test, Pharmacia Diagnostics, Piscataway, N.J.) after 20 h of incubation at 36°C in 5% CO2. All broth cultures were tested with groups A and B streptococcal antisera. Group A antiserum served as a negative control.
Those cultures positive for GBS were retested with the second swab from the dual-culture swab set. The second swab was inoculated into 2 ml of enriched, selective Todd-Hewitt broth. The broth culture was mixed vigorously with a Vortex-Genie mixer (Scientific Industries, Inc., Bohemia, N.Y.), serially diluted in 0.85% saline, and plated onto duplicate plates of Columbia colistin-nalidixic acid agar with 5% sheep blood (GIBCO). The number of CFU was determined by taking the average of duplicate plate counts after incubation of the plates for 24 h at 36°C in 5% CO2.
This second broth culture was retested for GBS by slide coagglutination immediately after inoculation (2, 10, 13) . Ryan and Barrett (14) recently reported the use of immunofluorescence to screen mothers and infants for GBS.
Selective broth medium is the single most sensitive method of detecting vaginal colonization of GBS (4, 7). In the past, however, broth cultures have been used to identify all colonized mothers, not specifically those at high risk of delivering symptomatic infants.
We describe in this study a screening program that utilizes an enriched, selective broth medium and slide coagglutination to specifically identify high-risk mothers. Coagglutination is a proven technique, shown to be 98% accurate in identifying streptococci (8, 12, 15) . The results of this study showed that coagglutination is sensitive in detecting GBS in broth cultures at concentra- These results indicate that mothers heavily colonized with GBS can be rapidly (0 to 5 h) identified by inoculating vaginal culture swabs into enriched, selective Todd-Hewitt broth with subsequent identification by slide coagglutination. These data, in combination with those from our previous report (11) that heavily colonized infants develop group B sepsis and the reports of others (1, 6) 
